Continuation of hormone replacement therapy after hysterectomy

References

• Moorhead T, Hannaford P, Warskyj M. Preva-lence and characteristics associated with use of hormone replacement therapy in Britain. Br J Obstet Gynaecol 1997;104:290–7
   Google Scholar
• Ludkin EG, Wahner HW, O'Fallon WM, et al. Treatment of postmenopausal osteoporosis with transdermal oestrogen. Ann Intern Med 1992; 117:1–9
   Google Scholar
• Stampfer MJ, Willett WC, Colditz GA, et al. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985;313:1044–9
   PubMed Web of Science ®Google Scholar
• Henderson VW, Paganini-Hill A, Emanuel CK, et al. Estogen replacement therapy in older women: comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 1994;51:896–900
   PubMed Web of Science ®Google Scholar
• Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal oestrogen treatment and stroke — a prospective study. Br Med J 1988;297: 519–22
   Google Scholar
• Garton M, Reid D, Rennie E. The climacteric, osteoporosis and hormone replacement; views of women aged 45–49. Maturitas 1995;21: 7–15
   Google Scholar
• Spector TD. Use of oestrogen replacement therapy in high risk groups in the United Kingdom. Br Med J 1989;299:1434–5
   PubMed Web of Science ®Google Scholar
• Panay N, Studd J. Hormone replacement therapy after hysterectomy. In Studd J, Edwards OL, eds. Hysterectomy and HRT. London: RCOG Press, 1997
   Google Scholar
• Drew SV, Rowe R, Panay N, Studd JWW. A general practice pilot audit study to assess advice and treatment offered to women following hysterectomy. Climacteric 1999;2:212–17
   PubMedGoogle Scholar
• Siddle N, Sarrel P, Whitehead MI. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with pre-mature loss of ovarian function and literature review. Fertil Steril 1987;47:94–100
   Google Scholar
• Watson N, Studd JWW, Garnett T, et al. Bone loss following hysterectomy with ovarian conser-vation. Obstet Gynecol 1995;86:72–7
   PubMed Web of Science ®Google Scholar
• Kaiser R, Kusche M, Wurz H. Hormone levels in women after hysterectomy. Arch Gynecol Obstet 1989;244:169–73
   PubMed Web of Science ®Google Scholar
• Coope J, Marsh J. Can we improve compli-ance with long term HRT? Maturitas 1992;15: 151–8
   PubMed Web of Science ®Google Scholar
• Halbert DR, Lloyd T, Rollings N, et al. Hormone replacement therapy usage: a 10 year experience of a solo practitioner. Maturitas 1998;29:67–73
   PubMed Web of Science ®Google Scholar
• Norman SG, Studd JWW. A survey of views on hormone replacement therapy. Br J Obstet Gynaecol 1994;101:879–87
   PubMedGoogle Scholar
• Isaacs AJ, Britton AR, McPherson K. Utilisation of hormone replacement therapy by women doctors. Br Med J 1995;311:1399–401
   PubMed Web of Science ®Google Scholar
• Andersson K, Pedersen AT, Mattsson LA, Milsom I. Swedish gynecologists' and general practitioners' views on the climacteric period: knowledge, attitudes and management strategies. Acta Obstet Gynecol Scand 1998;77:909–16
   PubMed Web of Science ®Google Scholar
• Bridgman SA, Dunn KM. Has endometrial ablation replaced hysterectomy for the treatment of dysfunctional uterine bleeding? National figures. Br J Obstet Gynaecol 2000;107:531–4
   Google Scholar
• Studd JWW. Shifting indications for hyster-ectomy. Lancet 1996;345:388
   Google Scholar
• Khastgir G, Studd J. Patients' outlook, experi-ence, and satisfaction with hysterectomy, bilateral oophorectomy, and subsequent con-tinuation of hormone replacement therapy. Am J Obstet Gynecol 2000;183:1427–33
   PubMed Web of Science ®Google Scholar
• Studd JWW, Chakravarti S, Collins WP. Plasma hormone profiles after the menopause andbilateral oophorectomy. Postgrad Med J 1978; 54:25–30
   Google Scholar
• Burger H, Hailes J, Nelson J. Effect of combined implants of oestradiol and testosterone on libido
   Google Scholar
• Brincat M, Studd JWW, O'Dowd T, et al. Sub-cutaneous hormone implants for the control of
   Google Scholar
• Khastgir G, Studd JWW. Hysterectomy, ovarian failure and depression. Menopause 1998;5: 113–22
   PubMed Web of Science ®Google Scholar
• Morris E, Rymer J. What are the treatment
   Google Scholar
• Leveille SG, LaCroix AZ, Newton KM, Keenan NL. Older women and hormone replacement
   Google Scholar
• Salamone LM, Pressman AR, Seeley DG, Cauley JA. Estrogen replacement therapy: a survey
   Google Scholar
• Gavin NI, Thorp JM, Ohsfeldt RL. Determinants of hormone replacement therapy duration among
   Google Scholar
• Whitcroft SI, Crook D, Marsh MS, et al. Long-term effects of transdermal and oral hormone replacement therapies on serum lipid and lipoprotein concentrations. Obstet Gynecol 1992;166:950–5
   Google Scholar
• Griffith F. Women's health concerns: is the promotion of hormone replacement therapy for
   Google Scholar
• prevention important to women? Fam Pract 1995;12:54–9
   PubMed Web of Science ®Google Scholar
• Torgerson DJ, Donaldson C, Russell IT, et al. Hormone replacement therapy: compliance and cost after screening for osteoporosis. Eur J Obstet Gynecol Reprod Biol 1995;59:57–60
   PubMed Web of Science ®Google Scholar
• Nachtigall LE. Enhancing patient compliance with hormone replacement therapy at meno-pause. Obstet Gynecol 1990;75 (Suppl 4): 77S–80S
   Google Scholar
• Mattson LA, Milsom I, Stadberg E. What do women want? Br J Obstet Gynaecol 1996; 103(Suppl 13):104–6
   PubMedGoogle Scholar
• Ettinger B, Pressman A, Silver P. Effect of age on reasons for initiation and discontinuation of hormone replacement therapy. Menopause 1999; 6:282–9
   Google Scholar
• Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 1995;122:9–16
   PubMed Web of Science ®Google Scholar
• Schneider DL, Barrett-Connor EL, Morton DJ. Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo study. J Am Med Assoc 1997;277:543-7 Michaelsson K, Baron JA, Farahmand BY, et al. Hormone replacement therapy and risk of hip fracture: population based case—control study. Br Med J 1998;316: 1858–63
   Google Scholar
• Gangar KF, Fraser D, Whitehead MI, Cust MP. Prolonged endometrial stimulation associated with oestradiol implants. Br Med J 1990;300: 436–8
   PubMed Web of Science ®Google Scholar
• Savvas M, Studd JW, Norman S, Leather AT, Garnett TJ, Fogelman I. Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens. Br J Obstet Gynaecol 1992;99: 757–60
   PubMedGoogle Scholar
• Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen and progestin in healthy postmenopausal women. Principal results from the Women's Health Initia-tive randomized controlled trial. J Am Med Assoc 2002;288:321–33
   Google Scholar